XML 406 R43.htm IDEA: XBRL DOCUMENT v3.24.3
Collaboration and License Agreements - Revenue (Details) - USD ($)
$ in Thousands
12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2022
Disaggregation of Revenue [Line Items]      
Revenue $ 3,551 $ 240,735 $ 243,231
GSK      
Disaggregation of Revenue [Line Items]      
Revenue 2,685 29,657 124,764
Horizon      
Disaggregation of Revenue [Line Items]      
Revenue 0 23,206 29,181
Takeda      
Disaggregation of Revenue [Line Items]      
Revenue 866 162,516 85,834
Janssen      
Disaggregation of Revenue [Line Items]      
Revenue 0 356 3,452
Amgen      
Disaggregation of Revenue [Line Items]      
Revenue $ 0 $ 25,000 $ 0